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In the spontaneous menstrual cycle, the mid-cycle 
gonadotrophin surge causes maturation of the cumulus- 
oocyte complex, mucification of cumulus cells and 
expansion of the cumulus oophorus, resumption of meiosis 
and maturation of the cytoplasm of the oocyte. Whether 
this is an effect purely of luteinizing hormone (LH) or 
whether follicle stimulating hormone (FSH) also plays a 
role is unknown. The effect of an artificially induced 
FSH surge at the time of human chorionic gonadotrophin 
(HCG) injection on maturation of the cumulus-oocyte 
complex was investigated in a prospective randomized 
double-blind trial. Twelve patients underwent controlled 
ovarian hyperstimulation [long gonadotrophin-releasing 
hormone agonist (GnRHa)/human menopausal gonadotro­
phin (HMG) protocol] for in-vitro fertilization (IVF) 
treatment. At the time of HCG administration, six 
patients received a bolus injection of FSH (450 IU i.m.); 
the other six patients received a placebo. The peak 
plasma concentrations of FSH of the experimental group 
were compared with the peak values of FSH obtained 
at the mid-cycle gonadotrophin surge of the natural cycle 
of a group of 12 volunteers to validate the bolus injection 
of FSH. Maturation of the cumulus-oocyte complex was 
quantified by measuring the expansion of the cumulus, 
by the fertilization rate and the implantation rate. The 
quality of the embryos was scored according the average 
morphology score. The bolus injection of FSH mimicked 
the mid-cycle gonadotrophin surge. The mean peak 
value of FSH (12.9 IU/1) in the experimental group was 
fully comparable with the mean peak value of FSH 
(10.0 IU/1) of the mid-cycle gonadotrophin surge in the 
natural cycle. No effect of a bolus injection of FSH on
the maturation of the cumulus-oocyte complex or any 
other outcome variable was found. It is not advantageous 
to combine the final HCG injection with a bolus injection 
of FSH in GnRHa/HMG stimulated cycles.
Key words: FSH surge/human/IVF/maturation cumulus- 
oocyte complex
Introduction
In the spontaneous menstrual cycle the mid-cyclic gonadotro­
phin surge causes the final event of the ovulatory process, 
maturation of the cumulus-oocyte complex, follicle rupture 
and luteinization. The cumulus oophorus mucifies and 
expands. The oocyte resumes meiosis till the second 
metaphase and becomes capable of being fertilized 
(Vermeiden and Zeilmaker, 1974; Thibault and Levasseur, 
1988). During the mid-cyclic gonadotrophin surge, both 
luteinizing hormone (LH) and follicle stimulating hormone 
(FSH) are secreted. In stimulated cycles using gonadotrophin- 
releasing hormone agonist (GnRHa), the human chorionic 
gonadotrophin (HCG) injection fully mimics LH, but the 
FSH surge is absent.
Many animal experiments have suggested a role for FSH 
in the maturation of the cumulus-oocyte complex (Eppig, 
1980; Behrman et a l , 1988; Buccione et a l , 1990; Chen 
et a l , 1994; Schramm and Bavister, 1994; Byskov et a l , 
1997). It has been shown in mice that FSH, and not LH, 
stimulates cumulus expansion and mucification in vitro by 
stimulating granulosa cells to synthesize and secrete hyalu­
ronic acid (Chen et al., 1994). FSH stimulates plasminogen 
activator, causing lysis of connective tissue and leading to 
ovulation in mice (Reich et a l , 1985). There is also some 
evidence from in-vitro studies that FSH affects maturation 
of the cumulus-oocyte complex in humans (Gomez et al., 
1993). The concentrations of FSH in follicular fluid correlate 
with the degree of maturation of the cumulus-oocyte 
complexes (Laufer et a l , 1984; Suchanek et a l , 1994), 
suggesting an in-vivo relationship. This raises the question 
whether induced elevated plasma FSH concentration during 
the final pre-ovulatory maturation events, comparable with 
the elevated concentration of plasma FSH during the mid­
cycle gonadotrophin surge, has a positive effect on the final 
maturation processes of the cumulus-oocyte complex in 
women treated with ovarian hyperstimulation.
The aim of this study was to assess the effect of a bolus 
injection of FSH concomitant with the HCG injection on 
cumulus expansion, fertilization rate, embryo quality and 
implantation rate.
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Materials and methods
Patients
In order to assess the effect of a bolus injection of FSH at the time 
of HCG administration, a prospective randomized double-blind trial 
was performed. Patients were fully informed of the objective and 
practical outlay of the experiment and had given written informed 
consent. Twelve patients participated in the experiment. All received 
conventional ovarian hyperstimulation using a long protocol GnRHa/ 
HMG (human menopausal gonadotrophin) until the minimum criteria 
for HCG administration were met. Using sealed envelopes, randomiz­
ation of the patients into the experimental or placebo group was 
effected on the day of HCG administration. The assignment of the 
groups was withheld from patients, medical and nursing staff and 
laboratory personnel. The code was broken after all patients had fully 
completed the in-vitro fertilization (IVF) treatment cycle and the 
results of the pregnancy test were known. The experimental group 
(FSH+ group) received HCG 10 000 IU i.m. plus a bolus injection 
of 450 IU FSH i.m., a dose designed to mimic the natural mid-cycle 
FSH surge, based on pharmacokinetic data (Le Contonnec et al, 
1993). The control group received HCG 10 000 IU i.m. plus an 
injection of saline i.m.
The patients in this study were between 18 and 38 years of age, 
and had a diagnosis of isolated tubal pathology. Patients with 
polycystic ovary syndrome, endometriosis externa grade II or more 
or oligomenorrhoea were excluded from this study. The partners 
exhibited normal semen parameters (the yield of fertile spermatozoa 
after Percoll 40/90 centrifugation was >5.0X106 per ejaculate, and 
a recovery of at least 10%). Couples with infertility caused by 
immunological factors (immunobead test > 20%), were excluded from 
the study.
On day 2 or 3 of the menstrual cycle (CD 2 or 3) a transvaginal 
sonographic examination was performed to exclude the presence of 
ovarian cysts. In order to exclude pregnancy, a blood sample was 
obtained. When plasma HCG levels were < 5 IU/1 patients commenced 
an oral contraceptive containing 30 jag of ethinyl oestradiol and 150 
|ig of levonorgestrel (Microgynon 30; Schering, Berlin, Germany) on 
CD 3, daily for 21 days. After 2 weeks, triptoreline acetate medication 
100 jag s.c. per day (Decapeptyl; Ferring, Malmo, Sweden) was
Table I. Definition of cumulus oophorus expansion
Score Stage of cumulus expansion
initiated (CD 17). The first day of the withdrawal bleeding (2-4 days 
after completion of the oral contraceptive regime) was CD 1 of the 
next cycle. Again, the presence of ovarian cysts was excluded by 
transvaginal sonography (CD 2).
Ovarian hyperstimulation with 225 IU HMG (Pergonal; Ares- 
Serono Laboratories Ltd, Welwyn Garden City, UK) was initiated on 
CD 3. The ovarian response was monitored using transvaginal 
ultrasonography and oestradiol determinations. When the minimum 
criteria for ovarian hyperstimulation were met (the largest follicle 18 
mm and at least three follicles >16 mm in diameter; serum oestradiol 
>1500 pmol/1) 10 000 IU of HCG (Profasi; Ares-Serono Laboratories 
Ltd, Welwyn Garden City, UK) were administered i.m. Concomitantly 
with the HCG administration, the experimental group received 450 
IU (six ampoules) of FSH i.m. (Metrodin; Ares-Serono Laboratories 
Ltd, Welwyn Garden City, UK), whereas the control group received 
a placebo (saline). Plasma FSH values were determined (Amerlite 
FSH assay monoclonal 2nd IRP 78/549; Amersham, UK) 5 min 
before (FSH 1), and 30 min (FSH 2), 10 h (FSH 3) and 34 h (FSH 
4) after HCG injection.
The estimation that 450 IU FSH mimicked the mid-cycle FSH 
surge was validated by comparing the plasma FSH concentration of 
the experimental groups with a study also performed in our centre. 
Twelve volunteers were monitored daily for one complete menstrual 
cycle. Blood samples were obtained and LH and FSH were measured.
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1
2
3
4
5
6 
7
Very compact cumulus and corona 
Compact cumulus and corona
Expanded fluffy cumulus and expanded corona radiata 
Fully expanded cumulus, radial corona 
Expanded cumulus, corona incomplete 
Incomplete corona, clumping of cumulus cells 
Totally denuded oocyte
The mid-cycle gonadotrophin surge was detected and the highest 
measured FSH concentration was compared with the plasma con­
centration of FSH of the experimental groups.
Transvaginal ultrasound guided puncture for oocyte retrieval took 
place 35 h after HCG injection. Luteal support was given with 
three daily doses of 200 mg micronized progesterone administered 
intravaginally (Progestan; Organon, Oss, The Netherlands).
Methods
The follicular aspirates were transferred to Petri dishes, and the 
oocyte-cumulus complexes were identified. A random sample of 
maximally 12 oocyte-cumulus complexes per patient was used for 
this study. After ovum retrieval the oocyte-cumulus complexes were 
spread with a glass pipette, and cumulus expansion was assessed. 
The expansion of the cumulus oophorus was expressed with a number 
ranging from one to seven (see Table I). Each oocyte was recorded 
on videotape for -10  s, and video recordings were also made of the 
embryos at day 1 and day 2 after ovum pick-up (VHS super tape). 
The oocytes and embryos in this study were incubated separately in 
Earle’s medium plus 1% human serum albumin (HSA), at 37°C under 
5% C02 in air.
The semen was processed using Percoll 40/90 discontinuous 
gradient centrifugation. Insemination with 50-1.00 000 progressively 
motile spermatozoa took place 2-6 h after ovum retrieval. At day 1 
after ovum retrieval, inspection for fertilization took place. At days
2 and 3 embryo quality was scored using the average morphology 
score as described earlier (Roseboom et a i , 1995). Embryo transfer 
took place either at day 2 or day 3 after ovum retrieval. In all patients 
three embryos were transferred.
Fertilization rate was expressed as the number of fertilized oocytes 
divided by the total number of oocytes per patient. Implantation rate 
was defined as the number of implantations (observed as embryonic 
cardiac activity at ultrasonography) divided by the number of trans­
ferred embryos. A vital pregnancy was defined as an ongoing 
pregnancy resulting in live birth.
Statistics
Mean values per patient plus standard deviations were given for age, 
FSH 1, FSH 2, FSH 3, FSH 4, number of oocytes, cumulus expansion, 
fertilization rate, average morphology score, number of embryos and 
implantation rate. A correlation matrix was constructed, and a Mann- 
Whitney Rank Sum test was performed.
Results
The mean age of the patients was 35.5 years in both groups. 
The mean plasma FSH value just prior to HCG administration 
in the FSH+ group and placebo group was 8.0 ±  2.2 IU/1 
and 7.8 ±  0.7 IU/1 respectively. The values obtained in the 
two groups 30 min, 10 and 34 h after HCG administration are
Artificially induced FSH surge
Table II. Mean values ±  SD {n = 6) per patient per treatment group. 
FSH+, i.m injection 450 IU FSI-I just before the final human chorionic 
gonadotrophin (HCG) injection. Placebo, saline injection just before the 
final HCG injection
FSH-f Placebo
Number of patients 6 6
Age (years) 35.5 (±1.1) 35,5 (±1.9)
FSH 1 (prior to HCG) 8,0 IU/1 (±2,2) 7.8 IU/1 (±0.7)
FSH 2 (30 min after HCG) 8.0 IU/1 (±2.1) 7.5 IU/1 (±0.6)
FSH 3 (10 h after HCG) 12.9 IU/1 (±2,8)* 6.6 IU/1 (±0.7)*
FSH 4 (34 h after HCG) 10.0 IU/1 (±1.9)* 4.5 IU/1 (±0.5)*
No. oocytes per patient 14.3 (±5.8) 13.8 (±4.3)
Cumulus expansion score 3,4 (±0.8) 3.1 (±0.6)
Fertilization rate (%) 74.8 (±13.8) 66.7 (±17.9)
Morphology score 0.47 (±0.6) 0.34 (±0.3)
No. embryos per patient 11.2 (±5.8) 9.0 (±2,8)
Vital pregnancies 3 (50) 4 (67)
(% per patient)
Implantation rate (%) 16.6 (±18.1) 44.2 (±40.2)
♦Statistically significant difference between the two groups, P <  0,004,
shown in Table II. By 10 h after HCG, mean plasma FSH was 
12.9 ±  2.8 IU/1 and 6.6 ±  0.7 IU/1 in the FSH+ and placebo 
groups respectively. The FSH values 10 and 34 h after HCG 
were significantly different between the two groups (P  <
0.004). Of the 12 volunteers in whom the FSH concentrations 
were monitored during one menstrual cycle, one had no mid­
cycle gonadotrophin surge, and so her values were not included. 
The mean of the highest mid-cycle FSH plasma concentrations 
of the other 11 volunteers was 10.0 ±  4.2 IU/1. The mean of 
the lowest plasma FSH concentration just before the mid-cycle 
gonadotrophin surge was 3.5 ±  0.8 IU/1 (P <  0.0015).
No differences were found between the two experimental 
groups in number of oocytes retrieved per patient, average 
degree of cumulus expansion, mean fertilization rate, mean 
number of embryos, average embryo morphology score, 
implantation rate or pregnancy rate (see Table II).
In the FSH group, three vita] pregnancies occurred and 
three singletons were born. In the placebo group, four vital 
pregnancies and one biochemical pregnancy occurred, and 
there were one triplet, two twins and one singleton live births. 
The average implantation rate per embryo per patient was 
16.6 ±  18.1 in the FSH group and 44.2 ±  40.2 in the 
placebo group.
In the correlation matrix, no correlations were found between 
any of the parameters. By example, the correlation coefficient 
of plasma FSH concentrations (FSH3) and the degree of 
cumulus expansion was 0.30 (not significant).
Discussion
A bolus injection of 450 IU FSH mimics the natural mid­
cycle FSH surge. The peak plasma FSH values (FSH3) 
measured in the FSH-h group were fully comparable with the 
peak values measured in the natural cycle (mean values 12.9 
±  2.8 IU/1 versus 10.0 ±  1.9 IU/1), The plasma FSH values
10 and 34 h after HCG administration (FSH3 and FSH4) were
significantly higher in the group that received a bolus injection 
of FSH compared with the placebo group. Despite the signific­
ant differences in FSH values between the two groups, no 
significant differences could be found in cumulus expansion, 
fertilization rate, embryo morphology and implantation rate. 
No correlation was found between plasma FSH values and 
average cumulus expansion per patient.
The bolus injection of FSH had no measurable effect. This 
can be explained by the observations that the FSH concentration 
at the time of the final maturation of the cumulus-oocyte 
complex is not related to plasma FSH concentration in follicular 
fluid. Pre-ovulatory follicles can accumulate FSH (Laufer 
et a l , 1984; Bernardus, 1993; Suchanek et al., 1994), and 
have their own regulatory mechanism by which their cumulus- 
oocyte complexes are exposed to different concentrations 
of FSH.
In the FSH+ and placebo groups, the mean plasma FSH 
concentration before the final HCG injection was ~8 IU/1 
(Table II). This is approximately two times higher than the 
mean plasma FSH concentration in the spontaneous cycle 
before the mid-cycle gonadotrophin surge (3,5 IU/1), In cycles 
with ovarian stimulation, FSH is available in relative excess 
at the time of the final HCG injection. This FSH concentration 
does not induce the final maturation of the cumulus-oocyte 
complex. In patients in whom ovum retrieval was attempted 
without bioavailability of HCG, no mature cumulus-oocyte 
complexes were obtained (Ndukwe et al., 1996). It must be 
concluded that HCG is essential for the triggering of the final 
maturation process of the cumulus-oocyte complex. However, 
the degree of maturation of the cumulus oophorus is correlated 
with the follicular fluid concentration of FSH (Laufer et a l , 
1984; Suchanek et a l , 1994) and not to the concentration of 
any other hormone (oestradiol, progesterone, testosterone or 
HCG) present in the follicular fluid (Enien et a l ,  1995). This 
is a strong indication for a permissive or synergistic role of 
FSH in the maturation process of the cumulus-oocyte complex.
There is, however, an alternative explanation. The accumula­
tion of FSH in follicular fluid is an indicator of follicular 
‘health1, of the potency of the follicle to respond to the mid­
cycle LH surge or to final HCG injection. Accumulation of 
FSH and maturation of the cumulus-oocyte complex thus 
represent two independent phenomena, each reflecting the 
competency of the follicle.
The pregnancy rate and the implantation rate in this study 
were high (Table II). This can partly be attributed to chance 
(the group is small). The group of patients included in this 
study were infertile due to isolated tubal pathology, which has 
been shown to have a high probability of pregnancy after IVF 
treatment (Roseboom et a l , 1995). The implantation rate found 
in the placebo group was high, though not statistically different 
from the implantation rate in the FSH group (16.6 versus 
44.2%, P =  0.21). From a scientific point of view, a larger 
study would be justified in order to assess whether an excess 
of FSH at the time of HCG administration has a negative 
effect on implantation. However, such a study cannot be
justified clinically.
Since no beneficial effect of a bolus injection of FSH at the 
time of HCG administration could be found on any outcome
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variable, it is not advantageous to mimic the natural mid-cycle 
FSH surge in IVF cycles by giving a bolus injection of FSH.
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